Trial intelligence / Profile preview

Atomoxetine for post-stroke neural plasticity

NCT02788357Phase 2Completed

Start
Nov 2006
Primary completion
Dec 2012
Modality
Small Molecules
01

Overview

A Phase 2 trial of atomoxetine in stroke. Started Nov 2006; status: completed.

02

Drugs

atomoxetine
03

Conditions

stroke

Beyond the preview

Go deeper on NCT02788357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02788357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call